PROFILE

1997-1998 Rockefeller University Molecular Neuro-Immunology (Post-Doc)

1988-1995 Seoul National University Graduate School (PhD)

1982-1988 Seoul National University College of Medicine (MD)

2026-2026 Korean Society for Biochemistry and Molecular Biology (President)

2023-2023 Korea Genome Organization (President)

2018-Present Geninus Inc. (CEO)

2013-Present Sungkyunkwan University School of Medicine (Professor)

2013-2025 Samsung Medical Center Samsung Genome Institute (Director)

1998-2012 Seoul National University College of Medicine (Professor)

1. Mutation-specific dynamics of dedifferentiation trajectories and tumor-stromal interactions in thyroid cancer. Mol Cancer. 2026 Jul 16;25(1):175.

2. A spatially resolved human glioblastoma atlas reveals distinct cellular and molecular patterns of anatomical niches. Nat Commun. 2026 Feb 20;17(1):2951.

3. Asian diversity in human immune cells. Cell. 2025 Apr 17;188(8):2288-2306.

4. ATG7 in innate immune cells is required for host defense against nontuberculous mycobacterial pulmonary infections. Nature Commun. 2025 Jul 29;16(1):6966.

5. Germline functional variants contribute to somatic mutation and outcomes in neuroblastoma. Nature Commun. 2024 Sep 27;15(1):8360.